Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03731351 · ClinicalTrials.gov registry record
Mild Acute Ischemic Stroke With Large Vessel Occlusion (MISTWAVE)
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 20
- Enrollment target
NCT03731351: Completed study, sponsored by The Cleveland Clinic.
NCT03731351 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03731351 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Stroke remains the leading cause of disability in the United States. An estimated 40-50% of all ischemic strokes are caused by large-vessel occlusion of a major cerebral artery (LVO). However, in some cases, the occlusion results in mild symptoms, at least initially, and these patients frequently do not receive any treatment. These strokes, however, may result in unfavorable long-term outcomes despite relatively benign initial course. Recent large randomized studies in patients with severe stroke symptoms and associated LVO showed efficacy and safety of endovascular mechanical thrombectomy, but patients with mild symptoms were not specifically addressed. Based on the investigators' own data and limited evidence in the literature, the investigators propose that early mechanical thrombectomy in patients with LVO associated with mild stroke symptoms (defined as NIHSS ≤ 5) is safe, and results in favorable long-term patient outcomes. The objective of this prospective pilot study is to assess the safety and outcomes of mechanical thrombectomy in patients presenting with acute ischemic stroke due to a large vessel occlusion in the anterior or posterior circulation under 24 hours with mild symptoms (NIHSS ≤ 5).
Primary Outcome
European Cooperative Acute Stroke Study (ECASS) classification: hemorrhagic infarct type 1 (HI1): small petechiae along the periphery of the infarct; hemorrhagic infarct type 2 (HI2): confluent petechiae within the infarcted area without a space-occupying effect; parenchymal hematoma type 1 (PH1): bleeding \</= 30% of the infarcted area with a mild space-occupying effect. parenchymal hematoma type 2 (PH2): bleeding \> 30% of the infarcted area with a significant space-occupying effect
Interventions
- PROCEDURE Mechanical Thrombectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-08-03 |
| Est. Completion | 2018-12-01 |
What the finished NCT03731351 record still lists
NCT03731351 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Mechanical Thrombectomy is the first listed.
NCT03731351 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03731351 about?
NCT03731351 is a clinical study titled "Mild Acute Ischemic Stroke With Large Vessel Occlusion (MISTWAVE)". Stroke remains the leading cause of disability in the United States. An estimated 40-50% of all ischemic strokes are caused by large-vessel occlusion of a major cerebral artery (LVO). However, in some cases, the occlusion results in mild symptoms, at least initially, and these patients frequently do...
What is the current status of trial NCT03731351?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2016-08-03. Estimated completion is 2018-12-01.
What interventions are being tested in trial NCT03731351?
The interventions under investigation include: Mechanical Thrombectomy (PROCEDURE).
Who is sponsoring clinical trial NCT03731351?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI